Medical Industry News | Cardiology

Editor's Choice

The case for implantable cardiac defibrillators, cardiac resynchronization therapy in older patients

Although implantable cardiac defibrillators reduce mortality through primary and secondary prevention of cardiac arrest, and cardiac resynchronization therapy improves exercise tolerance, quality of life, and decreases mortality and hospitalizations, both strategies are underutilized in older patients. Recommending device placement to patients requires a discussion of indication, risks, and benefits, as well as plans for deactivation in end-stage disease.

LATEST ARTICLES

Easier pediatric blood pressure screening

Dr. Andrew Schuman recently sat down with Dr. David Kaelber to discuss the implications of his vastly simplified screening tool for pediatric hypertension.

P&T considerations in fashioning a knowledge base, action plan for cardiometabolic disorders and weight

The P&T committee is positioned to provide knowledge, strategies to improve treatment of patients with cardiometabolic disorders.

First visit of a 47-year-old woman with severe hypertriglyceridemia and type 2 diabetes (CME)

First visit of a 47-year-old woman with severe hypertriglyceridemia and type 2 diabetes

Second visit of a 47-year-old woman with severe hypertriglyceridemia and type 2 diabetes (CME)

Second visit of a 47-year-old woman with severe hypertriglyceridemia and type 2 diabetes

The case for implantable cardiac defibrillators, cardiac resynchronization therapy in older patients